Faculty Information |
|
Article types | Original article |
Language | English |
Refereed paper | Refereed |
Title | Comparative analysis of the therapeutic outcomes of atezolizumab plus bevacizumab and lenvatinib for hepatocellular carcinoma patients aged 80 years and older: Multicenter study |
Journal | Formal name:Hepatology Research ISSN code:13866346 |
Domestic / Foregin | Foregin |
Volume, Number, Page | pp.382-391 |
Papers・Author | Hatanaka Takeshi, Kakizaki Satoru, Hiraoka Atsushi, Tada Toshifumi, Hirooka Masashi, Kariyama Kazuya, Tani Joji, Atsukawa Masanori, Takaguchi Koichi, Itobayashi Ei, Fukunishi Shinya, Tsuji Kunihiko, Ishikawa Toru, Tajiri Kazuto,Ochi Hironori, Yasuda Satoshi, Toyoda Hidenori, Ogawa Chikara,Yokohama Keisuke, Nishikawa Hiroki, Nishimura Takashi, Shimada Noritomo, Kawata Kazuhito,Kosaka Hisashi,Naganuma Atsushi Yata Yutaka, Ohama Hideko, Kuroda Hidekatsu, Aoki Tomoko, Tanaka Kazunari, Tanaka Takaaki, Tada Fujimasa, Nouso Kazuhiro, Morishita Asahiro, Tsutsui Akemi, Nagano Takuya, Itokawa Norio, Okubo Tomomi, Arai Taeang, Imai Michitaka,Koizumi Yohei, Nakamura Shinichiro, Kaibori Masaki, Iijima Hiroko, Hiasa Yoichi, Kudo Masatoshi,Kumada Takashi. Real-life Practice Experts for HCC (RELPEC) Study Group, and HCC 48 Group (hepatocellular carcinoma experts from 48 clinics in Japan) |
Publication date | 2024/04 |